IKAP Antibodies

Santa Cruz Biotechnology features a diverse variety of IKAP Antibodies for research focused on understanding IKAP protein functions. IKAP Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IKAP, also known as IKBKAP, plays a key role in regulating the NF-kB signaling pathway, which influences immune response, cell survival, and inflammation. Mutations in IKAP genes are linked to familial dysautonomia, emphasizing its significance in neuronal development and function. Research has shown that IKAP expression patterns vary across different tissue types and developmental stages. Understanding IKAP's molecular mechanisms and interactions can reveal new insights into disease pathways and potential treatments. Investigating IKAP's role in cellular processes helps advance knowledge about neurological disorders and inflammatory conditions. Current studies continue to uncover new functions and regulatory mechanisms of IKAP in various biological processes. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of IKAP's role in health and disease.